硫糖化物作为细菌甘油生物合成的代谢抑制剂起作用
Isabella de la Luz Quintana1, Ankita Paul2, Aniqa Chowdhury1
1Department of Chemistry & Biochemistry, Bowdoin College, 6600 College Station, Brunswick, Maine 04011, United States.
ACS infectious diseases
|September 12, 2023
概括
新型硫糖化物 (S-糖化物) 有效抑制细菌糖甘生物合成,并影响细菌的健康. 这些化合物表现出增强的选择性,为开发针对细菌葡萄糖的抗生素提供了一个有希望的新途径.
科学领域:
- 微生物学 微生物学
- 葡萄糖生物学 葡萄糖生物学
- 药用化学 医学化学
背景情况:
- 细菌表面的甘氨酸对病变产生至关重要,并代表了可行的抗生素标.
- 破坏细菌糖甘生物合成是一种抑制宿主感染的策略.
- 甲基糖化物以前已经显示出作为细菌糖甘生物合成的代谢抑制剂的潜力.
研究的目的:
- 合成和评估基于罕见细菌单糖的新型硫糖化物 (S-糖化物) 作为细菌糖甘生物合成的潜在抑制剂.
- 评估这些S-糖化物对病原和有益细菌以及哺乳动物细胞的疗效和选择性.
主要方法:
- 使用罕见的细菌单糖的S-糖化物组合的合成.
- 评估S-糖化物对致病性和有益细菌中的糖生物合成和细菌适应性的影响.
- 评估S-糖化物对哺乳动物细胞糖化和生长的影响.
主要成果:
- 新型的S-糖化物有效地改变了甘氨酸的生物合成,并降低了致病细菌的适应性.
- 在有益细菌或哺乳动物细胞中没有观察到对糖化或生长的显著影响.
- 在细菌中,S-糖化物表现出与O-糖化物相当的强度,但具有更强的选择性.
结论:
- 新型S-糖化物是细菌糖甘生物合成的有效和选择性抑制剂.
- 这些化合物为选择性向细菌葡萄糖提供了一个有希望的战略.
- 开发的S-糖化物代表了抗生素武器库对抗细菌感染的潜在扩张.
相关概念视频
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
203
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...
Acarbose and miglitol are...
203
Oral Hypoglycemic Agents: Biguanides and Glitazones
230
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
230
Biosynthesis of Polysaccharides
37
Polysaccharides such as glycogen and starch are synthesized from nucleoside diphosphate sugars, primarily uridine diphosphate glucose (UDPG) and adenosine diphosphate glucose (ADPG). These activated glucose donors act as key intermediates in carbohydrate metabolism and biosynthesis. UDPG primarily involves glycogen synthesis in animals and many bacteria, while ADPG plays a fundamental role in starch synthesis in plants and certain bacteria.UDPG is formed when glucose-1-phosphate reacts with...
37
Types of RNA
63.9K
Overview
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
63.9K
Dipeptidyl Peptidase 4 Inhibitors
211
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
211
Oral Hypoglycemic Agents: Glinides
183
Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively...
183


